China Plans To Crackdown On Private Tutoring Companies: Reuters
China is planning a tough crackdown on the country's $120 billion private tutoring industry, Reuters reported.
These OTC Securities had the Most Trading Activity in May
Photo by Karsten Winegeart on Unsplash
Altimmune’s ALT-801 Achieves 5.4% Weight Loss Surpassing Pre-Established Target Of 2%
Altimmune Inc (NASDAQ: ALT) announced results from a prespecified 6-week interim analysis of its Phase 1 trial of ALT-801 in healthy, overweight, and obese volunteers.
The study is currently being conducted in Australia.
MannKind – United Therapeutics’ Formulated Treprostinil Under FDA Review For Pulmonary Hypertension
MannKind Corporation (NASDAQ:MNKD) and United Therapeutics Corporation (NASDAQ:UTHR) have announced that the FDA has accepted for review the marketing application of Tyvaso DPI…
24 Stocks Moving in Wednday’s Pre-Market Session
Gainers
Catabasis Pharmaceuticals, Inc. (NASDAQ: CATB) rose 43.6% to $2.93 in pre-market trading after a 13G filing from Ra Capital showed a 7.5% stake in the company.
RAPT Therapeutics Raises $125M Via Equity At 6% Discount
RAPT Therapeutics Inc (NASDAQ:RAPT) has priced its previously announced underwritten public offering of 3.8 million shares at $33/share. The price represents…
Protagonist Therapeutics Secures $115M Via Equity Raise
Protagonist Therapeutics Inc (NASDAQ:PTGX) priced its previously announced underwritten public offering of around 3 million common shares to raise gross proceeds…
Spero Therapeutics Kick Starts Two SPR206 Trials For Bronchoalveolar Lavage, Renal Impairment
Spero Therapeutics Inc (NASDAQ:SPRO) initiated two Phase 1 trials of SPR206, including bronchoalveolar lavage (BAL) trial assessing the penetration of…
United Therapeutics Announces FDA Acceptance Of Tyvaso DPI New Drug Application For Priority Review
United Therapeutics Corporation (NASDAQ: UTHR) today announced that the U.S.
44 Biggest Movers From Yesterday
Gainers
Alzamend Neuro, Inc. (NASDAQ: ALZN) shares jumped 170% to close at $13.50 on Tuesday after the company priced its IPO at $5 per share.